RxDoctor Payments Data

Michelle Rainey

Family · Goodlettsville, TNNPI 1558958983

Payments from drug & device makers

$9,670in general payments, 2019–2025

Across 324 payments — averaging $29.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Intuitive Surgical$5K
  • AbbVie$919
  • Novo Nordisk$843
  • Lilly USA, LLC$339
  • Boehringer Ingelheim$337
  • GSK$266
  • plus $2K from 27 others

What the payments were for

  • Travel & lodging$5,43156%
  • Food & beverage$4,23944%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,670 in reported general payments places this provider in the 95th percentile of 6,706 family providers in Tennessee.

See all family providers in Tennessee

Medicare billing

Part B allowed, 2024
$20,468
Medicare patients
110
Services billed
1,028

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin70$78,717
MounjaroTirzepatide19$25,939
EliquisApixaban26$21,418
XareltoRivaroxaban14$20,835
JanuviaSitagliptin Phosphate21$19,480
Trelegy ElliptaFluticasone/Umeclidin/Vilanter18$16,321
VascepaIcosapent Ethyl16$7,010
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$6,014
Rosuvastatin Calcium132$2,117
Atorvastatin Calcium205$1,869
Duloxetine Hcl49$1,389
Losartan Potassium117$1,288
Omeprazole76$1,210
Levothyroxine Sodium105$924
SynthroidLevothyroxine Sodium20$913

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$337$78,71770 claims
Lilly USA, LLCMounjaro$339$25,93919 claims
GSKTrelegy Ellipta, Anoro Ellipta$266$22,33431 claims
PfizerEliquis$250$21,41826 claims
Johnson & JohnsonXarelto$174$20,83514 claims
MerckJanuvia$50$19,48021 claims
AbbVieSynthroid$919$91320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,706 family providers in Tennessee.

Other family in Goodlettsville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →